筛选条件 共查询到91条结果
排序方式
Adoptive therapy with cytomegalovirus-specific T cells for cytomegalovirus infection after haploidentical stem cell transplantation and factors affecting efficacy

期刊: AMERICAN JOURNAL OF HEMATOLOGY, 2022; 97 (6)

Adoptive therapy with cytomegalovirus (CMV)-specific cytotoxic T lymphocytes (CMV-CTLs) has emerged as an effective method for CMV infection. However,......

JIF:4.48

A novel adoptive synthetic TCR and antigen receptor (STAR) T-Cell therapy for B-Cell acute lymphoblastic leukemia

期刊: AMERICAN JOURNAL OF HEMATOLOGY, 2022; 97 (8)

We developed a T-cell-receptor (TCR) complex-based chimeric antigen receptor (CAR) named Synthetic TCR and Antigen Receptor (STAR). Here, we report pr......

JIF:4.48

COVID-19 vaccines and risks of hematological abnormalities: Nested case-control and self-controlled case series study

期刊: AMERICAN JOURNAL OF HEMATOLOGY, 2022; 97 (4)

Several studies reported hematological abnormalities after vaccination against the coronavirus disease 2019 (COVID-19). We evaluated the association b......

JIF:4.48

Anti-CD19 and anti-BCMA CAR T cell therapy followed by lenalidomide maintenance after autologous stem-cell transplantation for high-risk newly diagnosed multiple myeloma

期刊: AMERICAN JOURNAL OF HEMATOLOGY, 2022; 97 (5)

Few prospective studies have examined posttransplant chimeric antigen receptor (CAR) T cell infusion as candidates for front-line consolidation therap......

JIF:4.48

CAR-T cell therapy targeting B cell maturation antigen is effective for relapsed/refractory multiple myeloma, including cases with poor performance status

期刊: AMERICAN JOURNAL OF HEMATOLOGY, 2022; 97 (7)

In this open-label, single-arm, phase I/II clinical trial, we evaluated the efficacy of anti-B cell maturation antigen (BCMA) chimeric antigen recepto......

JIF:4.48

Efficacy of pp65-specific TCR-T cell therapy in treating cytomegalovirus infection after hematopoietic stem cell transplantation

期刊: AMERICAN JOURNAL OF HEMATOLOGY, 2022; 97 (11)

Cytomegalovirus (CMV) infection remains a major cause of mortality after hematopoietic stem cell transplantation (HSCT). Current treatments, including......

JIF:4.48

Chidamide plus prednisone, etoposide, and thalidomide for untreated angioimmunoblastic T-cell lymphoma in a Chinese population: A multicenter phase II trial

期刊: AMERICAN JOURNAL OF HEMATOLOGY, 2022; 97 (5)

Angioimmunoblastic T-cell lymphoma (AITL) is a common type of peripheral T-cell lymphoma (PTCL) with a poor prognosis, and an effective first-line the......

JIF:4.48

Single-dose versus low-dose rituximab in corticosteroid-resistant or relapsed ITP: A multicenter, randomized, controlled study

期刊: AMERICAN JOURNAL OF HEMATOLOGY, 2022; 97 (4)

Primary immune thrombocytopenia (ITP) is an autoimmune bleeding disorder, in which rituximab (RTX) induces the best long-term effect among recommended......

JIF:4.48

共91条页码: 1/7页15条/页